2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$278.87+$16.69 (+6.37%)
Price as of Jun 23, 2026 6:42 PM EDT- $5.3BMarket Cap
- 128.02%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$278.87+$16.69 (+6.37%)
LGND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $262.17 | ||
Change | -$12.71 (-4.62%) | ||
Open | $267.73 | ||
High | $272.79 | ||
Low | $245.00 | ||
Previous Close | $274.88 | ||
Volume | 819,520 | ||
30-Day Average Volume | 261,136 | ||
1-Week Change | 3.52% | ||
1-Month Change | 14.32% | ||
1-Year Change | 128.02% | ||
3-Year Change | 246.46% | ||
5-Year Change | 102.28% | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $1.5B | ||
Market Cap | $5.3B | ||
Enterprise Value | $6.1B | ||
Period: QTR TTM FY | |||
Revenue | $32.9M | ||
Net Income | -$13.3M | ||
Free Cash Flow | $48.5M | ||
EBIT | -$22.7M | ||
EBITDA | -$14.4M | ||
Net Working Capital | $824.7M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -425 | ||
Enterprise Value/Revenue | 187 | ||
P/B | 5 | ||
P/E | -391 | ||
PEG | 3 | ||
Price/Free Cash Flow | 108 | ||
Price/Operating Cash Flow | 108 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/02/2010 | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 11/19/2010 | ||
Earnings & Revenue